WHO approves Pfizer/BioNTech vaccine in breakthrough for developing nations wvlkam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wvlkam.com Daily Mail and Mail on Sunday newspapers.
WHO approves emergency use of Pfizer-BioNTech Covid vaccine
Issued on:
01/01/2021 - 11:03 A nurse prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a retirement home in France. REUTERS - POOL 2 min The World Health Organization has granted emergency validation to the Pfizer-BioNTech coronavirus vaccine, a decision that paves the way for countries to quickly approve its import and distribution. Advertising Read more
The US-German vaccine becomes the first to receive such approval from the global health body since the outbreak began a year ago. This is a very positive step towards ensuring global access to Covid-19 vaccines, said the WHO’s Mariangela Simao.
Pfizer/BioNTech vaccine approved by WHO in breakthrough for developing nations cnn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnn.com Daily Mail and Mail on Sunday newspapers.
The Citizen brings you breaking news, current affairs, celebrity and entertainment news, as well as sport news throughout the day. More news. Your way.
WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use
Regulatory experts convened by WHO from around the world and WHO’s own teams reviewed the data on the Pfizer/BioNTech vaccine’s safety, efficacy and quality as part of a risk-versus-benefit analysis.WHO | Geneva | Updated: 01-01-2021 08:52 IST | Created: 01-01-2021 08:52 IST
The Comirnaty vaccine requires storage using an ultra-cold chain; it needs to be stored at -60°C to -90°C degrees. Image Credit: ANI
The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.